SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $242,000 | +4.8% | 1,425 | -28.8% | 0.04% | -11.4% |
Q1 2020 | $231,000 | -60.6% | 2,000 | -61.1% | 0.04% | -46.3% |
Q4 2019 | $587,000 | +33.7% | 5,135 | 0.0% | 0.08% | +20.6% |
Q3 2019 | $439,000 | +23.7% | 5,135 | 0.0% | 0.07% | +51.1% |
Q2 2019 | $355,000 | -5.6% | 5,135 | 0.0% | 0.04% | -15.1% |
Q1 2019 | $376,000 | +29.2% | 5,135 | 0.0% | 0.05% | +8.2% |
Q4 2018 | $291,000 | -26.5% | 5,135 | 0.0% | 0.05% | -15.5% |
Q3 2018 | $396,000 | +16.1% | 5,135 | 0.0% | 0.06% | -6.5% |
Q2 2018 | $341,000 | +36.4% | 5,135 | +7.5% | 0.06% | +37.8% |
Q1 2018 | $250,000 | -2.0% | 4,775 | 0.0% | 0.04% | 0.0% |
Q4 2017 | $255,000 | -1.9% | 4,775 | 0.0% | 0.04% | -4.3% |
Q3 2017 | $260,000 | – | 4,775 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |